SunHydrogen has taken a significant step toward the mass production of its innovative hydrogen technology. The U.S.-based ...

The landscape of Hollywood is set for its most significant transformation in decades. In a landmark agreement finalized in ...

The Royal Bank of Canada (RBC) has closed its 2025 fiscal year with historic financial results, yet the landmark performance is generating complex questions alo ...

Biotechnology firm Ocugen has announced significant progress across its pipeline targeting inherited retinal diseases, ...

The S&P 500 has successfully broken free from a period of heightened volatility, closing two days ago with a solid 0.8% gain ...

COG Financial Services continues to execute its expansion strategy, building on a successful first half of the fiscal year.

MP Materials' latest financial results present a study in contrasts. While revenue declined significantly, profitability ...

A key regulatory filing has placed the future expense ratio of the actively managed Conductor Global Equity Value ETF under ...

As Altimmune moves beyond its 2025 fiscal year, the biopharmaceutical firm is squarely focused on a series of pivotal ...

The spotlight has returned to Strategy this week, driven not by its core software operations but by its aggressive Bitcoin purchasing program and a shifting pol ...

For biotechnology firms, a robust balance sheet is often the most critical asset. Sionna Therapeutics recently underscored ...

In a strategic move to enhance efficiency, Starbucks is relocating key operational control functions to the southeastern ...